The Valley Desk

Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished

Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published
Subject terms
Humans; Multiple Myeloma; Neoplasm, Residual; Hematopoietic Stem Cell Transplantation; Transplantation, Autologous; Flow Cytometry; Adult; Aged; Middle Aged; Female; Male; Maintenance Chemotherapy
PubMed ID
38701390
PubMed Central ID
PMC11634105
Added to directory
Source checked

Report a correction or request removal